Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker QTTB
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 4, 2026 | QTTB Q32 Bio Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 30, 2026 | QTTB Q32 Bio Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 30, 2026 | QTTB Q32 Bio Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 14, 2026 | QTTB Q32 Bio Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 14, 2026 | QTTB Q32 Bio Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 5, 2026 | QTTB Q32 Bio Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 15, 2026 | QTTB Q32 Bio Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jul 13, 2026 | QTTB Q32 Bio Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 13, 2026 | QTTB Q32 Bio Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 13, 2026 | QTTB Q32 Bio Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 16, 2026 | QTTB Q32 Bio Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 27, 2026 | QTTB Q32 Bio Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 27, 2026 | QTTB Q32 Bio Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| May 27, 2026 | QTTB Q32 Bio Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 5, 2026 | QTTB Q32 Bio Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 24, 2026 | QTTB Q32 Bio Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 27, 2026 | QTTB Q32 Bio Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 10, 2026 | QTTB Q32 Bio Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 17, 2026 | QTTB Q32 Bio Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 17, 2026 | QTTB Q32 Bio Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 19, 2025 | QTTB Q32 Bio Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 1, 2025 | QTTB Q32 Bio Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 1, 2025 | QTTB Q32 Bio Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 1, 2025 | QTTB Q32 Bio Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Dec 1, 2025 | QTTB Q32 Bio Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 1, 2025 | QTTB Q32 Bio Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 13, 2025 | QTTB Q32 Bio Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 21, 2025 | QTTB Q32 Bio Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 6, 2025 | QTTB Q32 Bio Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 25, 2025 | QTTB Q32 Bio Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 25, 2025 | QTTB Q32 Bio Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jun 17, 2025 | QTTB Q32 Bio Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 17, 2025 | QTTB Q32 Bio Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Jun 17, 2025 | QTTB Q32 Bio Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| May 23, 2025 | QTTB Q32 Bio Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| May 8, 2025 | QTTB Q32 Bio Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 25, 2025 | QTTB Q32 Bio Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 11, 2025 | QTTB Q32 Bio Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 10, 2025 | QTTB Q32 Bio Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 10, 2025 | QTTB Q32 Bio Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 10, 2025 | QTTB Q32 Bio Inc. | 2.05 Costs Associated with Exit or Disposal Activities | 8-K | 8-K ↗ |
| Jan 13, 2025 | QTTB Q32 Bio Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 11, 2024 | QTTB Q32 Bio Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 11, 2024 | QTTB Q32 Bio Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 7, 2024 | QTTB Q32 Bio Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
45 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:34 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances